-- One poster and one oral presentation selected, with the poster highlighting new preclinical data from the Company’s interferon-α receptor…
REDWOOD CITY, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel,…
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the pricing of (i) $45.0…
BOSTON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing…
– Live moderated webcast with Klaus Paulini, Chief Executive Officer of Aeterna Zentaris on Wednesday, October 25th at 10:00 AM…
Toronto, Ontario--(Newsfile Corp. - October 11, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the…
Extraordinary General Meeting called to approve the capital increase planned for January 2024 Drawdown of the first tranche of the…
GOTHENBURG, SE / ACCESSWIRE / October 11, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 11, 2023 - IRLAB Therapeutics…
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / October 10, 2023 / AGAPE ATP CORPORATION (NASDAQ:ATPC) ("AGAPE ATP" or the "Company"), an…
BOSTON & JOHANNESBURG--(BUSINESS WIRE)--Discovery Health, the leading health insurance administrator providing administration and managed care services to more than 3.8…